Science & Research
Foremost Clean Energy Ltd. Advances Uranium Exploration with ANT Survey in Athabasca Basin
Foremost Clean Energy Ltd. initiates an ANT survey at its Murphy Lake South Uranium Property to refine exploration targets and support the growing demand for nuclear energy.
GeoVax Advances Toward European Approval for Mpox Vaccine Following EMA Guidance
GeoVax Labs, Inc. has received positive Scientific Advice from the European Medicines Agency, paving the way for expedited approval of its GEO-MVA Mpox vaccine in the EU, potentially accelerating revenue generation.
Nobel Laureate Prof. J. Michael Kosterlitz Reflects on the Discovery and Impact of the Kosterlitz-Thouless Transition
Prof. J. Michael Kosterlitz, co-discoverer of the Kosterlitz-Thouless transition, shares insights into the discovery's challenges, implications, and its unforeseen applications in physics.
New Research Framework Enhances Water Health Diagnosis in China
A novel assessment framework proposed by a Chinese research team aims to improve water ecological health monitoring and diagnosis in China, addressing critical challenges in water quality and ecosystem resilience.
Creative Biolabs Advances Precision Medicine with Dual 3D Organoid and Tissue Slice Models
Creative Biolabs is enhancing precision medicine research by integrating 3D organoid and precision-cut tissue slice models, offering a more accurate and efficient approach to drug testing and disease modeling.
Study Reveals Early Health Visits May Predict Multiple Sclerosis Decades Before Diagnosis
A recent study indicates that individuals later diagnosed with multiple sclerosis visit healthcare providers more frequently decades before their diagnosis, suggesting potential for earlier intervention.
Soligenix Inc. Reports Promising Results in HyBryte(TM) Trial for Early-Stage Cutaneous T-Cell Lymphoma
Soligenix Inc.'s HyBryte(TM) shows promising treatment success in early-stage cutaneous T-cell lymphoma, offering hope for patients with limited options.
SeaStar Medical and AREVA Institute Collaborate on Innovative Burn Treatment Research with DoD Grant
A $2 million DoD grant supports SeaStar Medical and AREVA Institute's research into SCD therapy for reducing hyperinflammation in severe burns, potentially revolutionizing treatment for military and civilian patients.
Study Links Heart Scar Tissue to Dangerous Rhythms in Older Male Athletes
A U.K. study finds scar tissue in the heart may increase the risk of dangerous heart rhythms in healthy, long-time male endurance athletes over 50, highlighting the importance of monitoring and safety measures in sports.
Study Reveals Significant Proportion of Lung Cancer Patients Are Non-Smokers
Recent research highlights the puzzling prevalence of lung cancer among non-smokers, prompting urgent calls for further study and treatment development.
Micro Com Systems Pioneers in Scanning Historic Artifacts in Vancouver
Micro Com Systems in Vancouver offers specialized scanning services for historic artifacts, preserving invaluable historical data for future generations.
FDA Grants RMAT Designation to GNSC-001 for Knee Osteoarthritis Treatment
The FDA's RMAT designation for GNSC-001 highlights its potential as a groundbreaking gene therapy for knee osteoarthritis, offering long-term relief with a single injection.
ESGold Corp.'s ANT Survey Reveals Significant Potential at Quebec Site
ESGold Corp.'s recent ANT survey at the Montauban site in Quebec has uncovered a vertically continuous mineral system, suggesting the area may host more than a single deposit, marking a pivotal moment for the company's exploration efforts.
Critical Metals Corp Initiates Drilling Program in Greenland to Meet Western Demand for Rare Earth Materials
Critical Metals Corp has launched a 2000m drilling program at the Tanbreez Rare Earth Project in Greenland, aiming to increase the resource estimate and advance towards commercial production by 2026 to address the growing demand for rare earth materials in the West.
Modified Herpes Virus Shows Promise in Treating Advanced Melanoma
A recent study indicates that a genetically altered herpes virus could offer a new treatment avenue for advanced melanoma, highlighting the potential of oncolytic viruses in cancer therapy.
NanoViricides Advances MPox Treatment Amid WHO's Extended Health Emergency
NanoViricides, Inc. progresses with NV-387, a broad-spectrum antiviral drug, as the WHO extends the MPox global health emergency, highlighting the drug's potential to fill gaps in current treatments.
BioRestorative Therapies Reports Promising Phase 2 Trial Results for Chronic Pain Treatment
BioRestorative Therapies' phase 2 trial results for BRTX-100 show significant improvement in function and pain reduction for chronic lumbar disc disease patients, potentially paving the way for accelerated FDA approval.
GeoVax Advances Mpox Vaccine Development Amid Global Outbreak Concerns
GeoVax Labs accelerates its GEO-MVA vaccine candidate development following EMA's streamlined approval pathway, addressing the urgent need for diversified Mpox vaccine supply as global outbreaks expand.
Leading Health Experts Join American Heart Association Board to Combat Cardiovascular Diseases
The American Heart Association strengthens its leadership with the appointment of Dr. Jennifer Ashton and Dr. Joseph Woo to its Board of Directors, aiming to enhance cardiovascular and cerebrovascular health outcomes.
Heart-Healthy Habits Linked to Comprehensive Body Health Benefits
A decade-long review reveals that adhering to the American Heart Association’s Life’s Simple 7™ metrics for ideal cardiovascular health is associated with improved function across multiple bodily systems, underscoring the far-reaching benefits of heart-healthy lifestyles.
Creative Biolabs Enhances Antibacterial Drug Development with Integrated Mechanism and Pharmacokinetic Strategies
Creative Biolabs is revolutionizing antibacterial drug development by integrating mechanism identification and pharmacokinetic modeling early in the process to mitigate risks and enhance success rates.
Community Foundation of Broward Awards $900,000 in Grants for Cancer Research
The Community Foundation of Broward has awarded two grants totaling $900,000 to support innovative cancer research and treatment accessibility in Broward County, focusing on lung cancer biomarkers and melanoma immunotherapies.
China's New Predictive Model Could Revolutionize Lithium-ion Battery Safety
Chinese researchers have developed a predictive model that identifies potential failures in lithium-ion batteries early in their lifecycle, offering significant benefits for electric vehicle and energy storage industries.
Kairos Pharma Ltd. Reports Positive Safety Results in Phase 2 Study of Prostate Cancer Drug ENV-105
Kairos Pharma Ltd. announces favorable interim safety results from its Phase 2 trial of ENV-105 for metastatic castration-resistant prostate cancer, marking a significant step forward in cancer therapy.
Curebound Aims to Accelerate Cancer Cures Amid NIH Funding Cuts
Curebound, under the leadership of COO Karen Hooper, is intensifying efforts to fund innovative cancer research, especially critical in light of recent NIH funding cuts, to accelerate cures within our lifetime.
Alicia Kali's Test for Sentience Marks a New Era in AI Development
Alicia Kali introduces a groundbreaking Test for Sentience in AI, significantly reducing data storage needs by 90% and setting a new standard for machine cognition.
Lorati's Nano-Emulsion Offers New Hope for Stroke Recovery
Lorati Co., Ltd. introduces a natural, mineral-based nano-emulsion therapy that promises a non-invasive solution for full recovery from both hemorrhagic and ischemic strokes, marking a significant advancement in stroke treatment.
GeoVax to Showcase Vaccine and Cancer Therapy Progress at Emerging Growth Conference
GeoVax Labs, Inc. will present updates on its GEO-MVA, GEO-CM04S1, and Gedeptin® programs at the Emerging Growth Conference, highlighting advancements in vaccine development and cancer therapy.
NanoViricides Advances MPox Treatment with Adaptive Clinical Trial Design
NanoViricides, Inc. nears finalization of an adaptive clinical trial protocol for NV-387, a potential first-in-class treatment for MPox, highlighting its significance amid limited effective therapies.
ESGold Corp. Reveals District-Scale Potential at Montauban Gold-Silver Project
ESGold Corp.'s latest ANT survey at the Montauban Gold-Silver Project indicates a significant, deep-reaching mineralized system, suggesting the site could host a district-scale VMS system with substantial long-term mining potential.